世界の腎臓がん治療・診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Kidney Cancer Therapeutics and Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3317 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、腎臓がん治療・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（膀胱鏡検査、生検、静脈内腎盂造影、CTスキャン、腎臓超音波、その他）、用途別市場規模（病院、製薬研究所、ゲノミクス研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・腎臓がん治療・診断の市場動向 ・企業の競争状況、市場シェア ・腎臓がん治療・診断の種類別市場規模（膀胱鏡検査、生検、静脈内腎盂造影、CTスキャン、腎臓超音波、その他） ・腎臓がん治療・診断の用途別市場規模（病院、製薬研究所、ゲノミクス研究所、その他） ・腎臓がん治療・診断の北米市場規模2016-2027（アメリカ、カナダ） ・腎臓がん治療・診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・腎臓がん治療・診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腎臓がん治療・診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・腎臓がん治療・診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、Hoffmann La Roche、GlaxoSmithKline、Novartis、Pfizer、Abbott Laboratories、Amgen、Genentech、Cerulean Pharma、Seattle Genetics） ・結論

The occurrence of kidney cancer has increased in the recent years. Excessive smoking, rise in obesity because of sedentary life routines and increased consumption of alcohol are some of the causes of kidney cancer. The most common type of cancer is Renal Cell Carcinoma (RCC).Immunotherapies or targeted therapies are the most common prescribed treatments for kidney cancer.

Market Analysis and Insights: Global Kidney Cancer Therapeutics and Diagnostics Market
The global Kidney Cancer Therapeutics and Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Kidney Cancer Therapeutics and Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Kidney Cancer Therapeutics and Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Kidney Cancer Therapeutics and Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Kidney Cancer Therapeutics and Diagnostics market.

Global Kidney Cancer Therapeutics and Diagnostics Scope and Market Size
Kidney Cancer Therapeutics and Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Kidney Cancer Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cystoscopy
Biopsy
Intravenous Pyelogram
CT Scan
Kidney Ultrasound
Others

Segment by Application
Hospitals
Pharmaceutical Labs
Genomics Laboratories
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
Hoffmann La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Amgen
Genentech
Cerulean Pharma

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cystoscopy
1.2.3 Biopsy
1.2.4 Intravenous Pyelogram
1.2.5 CT Scan
1.2.6 Kidney Ultrasound
1.2.7 Others
1.3 Market by Application
1.3.1 Global Kidney Cancer Therapeutics and Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Pharmaceutical Labs
1.3.4 Genomics Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Kidney Cancer Therapeutics and Diagnostics Market Perspective (2016-2027)
2.2 Kidney Cancer Therapeutics and Diagnostics Growth Trends by Regions
2.2.1 Kidney Cancer Therapeutics and Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Kidney Cancer Therapeutics and Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Kidney Cancer Therapeutics and Diagnostics Industry Dynamic
2.3.1 Kidney Cancer Therapeutics and Diagnostics Market Trends
2.3.2 Kidney Cancer Therapeutics and Diagnostics Market Drivers
2.3.3 Kidney Cancer Therapeutics and Diagnostics Market Challenges
2.3.4 Kidney Cancer Therapeutics and Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Kidney Cancer Therapeutics and Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Kidney Cancer Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Kidney Cancer Therapeutics and Diagnostics Revenue
3.4 Global Kidney Cancer Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Kidney Cancer Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Therapeutics and Diagnostics Revenue in 2020
3.5 Kidney Cancer Therapeutics and Diagnostics Key Players Head office and Area Served
3.6 Key Players Kidney Cancer Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Kidney Cancer Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Cancer Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Kidney Cancer Therapeutics and Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Type (2022-2027)

5 Kidney Cancer Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Kidney Cancer Therapeutics and Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size (2016-2027)
6.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type
6.2.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2027)
6.3 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application
6.3.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2027)
6.4 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country
6.4.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size (2016-2027)
7.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type
7.2.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2027)
7.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application
7.3.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2027)
7.4 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country
7.4.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type
8.2.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application
8.3.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region
8.4.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size (2016-2027)
9.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type
9.2.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application
9.3.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country
9.4.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type
10.2.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application
10.3.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country
10.4.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Kidney Cancer Therapeutics and Diagnostics Introduction
11.1.4 Bayer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Hoffmann La Roche
11.2.1 Hoffmann La Roche Company Details
11.2.2 Hoffmann La Roche Business Overview
11.2.3 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Introduction
11.2.4 Hoffmann La Roche Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
11.2.5 Hoffmann La Roche Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Introduction
11.3.4 GlaxoSmithKline Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Kidney Cancer Therapeutics and Diagnostics Introduction
11.4.4 Novartis Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Kidney Cancer Therapeutics and Diagnostics Introduction
11.5.4 Pfizer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Details
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Introduction
11.6.4 Abbott Laboratories Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
11.6.5 Abbott Laboratories Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Kidney Cancer Therapeutics and Diagnostics Introduction
11.7.4 Amgen Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
11.7.5 Amgen Recent Development
11.8 Genentech
11.8.1 Genentech Company Details
11.8.2 Genentech Business Overview
11.8.3 Genentech Kidney Cancer Therapeutics and Diagnostics Introduction
11.8.4 Genentech Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
11.8.5 Genentech Recent Development
11.9 Cerulean Pharma
11.9.1 Cerulean Pharma Company Details
11.9.2 Cerulean Pharma Business Overview
11.9.3 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Introduction
11.9.4 Cerulean Pharma Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
11.9.5 Cerulean Pharma Recent Development
11.10 Seattle Genetics
11.10.1 Seattle Genetics Company Details
11.10.2 Seattle Genetics Business Overview
11.10.3 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Introduction
11.10.4 Seattle Genetics Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
11.10.5 Seattle Genetics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cystoscopy
Table 3. Key Players of Biopsy
Table 4. Key Players of Intravenous Pyelogram
Table 5. Key Players of CT Scan
Table 6. Key Players of Kidney Ultrasound
Table 7. Key Players of Others
Table 8. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Regions (2016-2021)
Table 12. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Regions (2022-2027)
Table 14. Kidney Cancer Therapeutics and Diagnostics Market Trends
Table 15. Kidney Cancer Therapeutics and Diagnostics Market Drivers
Table 16. Kidney Cancer Therapeutics and Diagnostics Market Challenges
Table 17. Kidney Cancer Therapeutics and Diagnostics Market Restraints
Table 18. Global Kidney Cancer Therapeutics and Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Players (2016-2021)
Table 20. Global Top Kidney Cancer Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Therapeutics and Diagnostics as of 2020)
Table 21. Ranking of Global Top Kidney Cancer Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Kidney Cancer Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Kidney Cancer Therapeutics and Diagnostics Product Solution and Service
Table 25. Date of Enter into Kidney Cancer Therapeutics and Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Type (2016-2021)
Table 29. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Kidney Cancer Therapeutics and Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Application (2016-2021)
Table 33. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Bayer Company Details
Table 66. Bayer Business Overview
Table 67. Bayer Kidney Cancer Therapeutics and Diagnostics Product
Table 68. Bayer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 69. Bayer Recent Development
Table 70. Hoffmann La Roche Company Details
Table 71. Hoffmann La Roche Business Overview
Table 72. Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Product
Table 73. Hoffmann La Roche Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 74. Hoffmann La Roche Recent Development
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Product
Table 78. GlaxoSmithKline Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 79. GlaxoSmithKline Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Kidney Cancer Therapeutics and Diagnostics Product
Table 83. Novartis Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 84. Novartis Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Kidney Cancer Therapeutics and Diagnostics Product
Table 88. Pfizer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 89. Pfizer Recent Development
Table 90. Abbott Laboratories Company Details
Table 91. Abbott Laboratories Business Overview
Table 92. Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Product
Table 93. Abbott Laboratories Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 94. Abbott Laboratories Recent Development
Table 95. Amgen Company Details
Table 96. Amgen Business Overview
Table 97. Amgen Kidney Cancer Therapeutics and Diagnostics Product
Table 98. Amgen Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Amgen Recent Development
Table 100. Genentech Company Details
Table 101. Genentech Business Overview
Table 102. Genentech Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 103. Genentech Recent Development
Table 104. Cerulean Pharma Company Details
Table 105. Cerulean Pharma Business Overview
Table 106. Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Product
Table 107. Cerulean Pharma Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 108. Cerulean Pharma Recent Development
Table 109. Seattle Genetics Company Details
Table 110. Seattle Genetics Business Overview
Table 111. Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Product
Table 112. Seattle Genetics Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 113. Seattle Genetics Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Cystoscopy Features
Figure 3. Biopsy Features
Figure 4. Intravenous Pyelogram Features
Figure 5. CT Scan Features
Figure 6. Kidney Ultrasound Features
Figure 7. Others Features
Figure 8. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Pharmaceutical Labs Case Studies
Figure 11. Genomics Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Kidney Cancer Therapeutics and Diagnostics Report Years Considered
Figure 14. Global Kidney Cancer Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Kidney Cancer Therapeutics and Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Regions: 2020 VS 2027
Figure 17. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Regions (2022-2027)
Figure 18. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Players in 2020
Figure 19. Global Top Kidney Cancer Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Therapeutics and Diagnostics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Kidney Cancer Therapeutics and Diagnostics Revenue in 2020
Figure 21. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Type (2016-2021)
Figure 22. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Type (2022-2027)
Figure 23. North America Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 25. North America Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 26. North America Kidney Cancer Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 27. United States Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 31. Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 32. Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 33. Germany Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Share by Region (2016-2027)
Figure 43. China Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 51. Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 52. Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 53. Mexico Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 59. Turkey Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Bayer Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
Figure 63. Hoffmann La Roche Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
Figure 67. Abbott Laboratories Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
Figure 68. Amgen Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
Figure 69. Genentech Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
Figure 70. Cerulean Pharma Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
Figure 71. Seattle Genetics Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---